Studies on a transgenic Alzheimer’s disease model (3xTgAD mice) demonstrated significant alterations in NMJ structure, including fragmentation and partial denervation, accompanied by reduced muscle contraction strength and accumulation of amyloid precursor protein (APP) and β-amyloid in muscle tissue [123]. The gene discussed is APP; the disease is Alzheimer disease.